138 related articles for article (PubMed ID: 31876779)
21. Nuclear accumulation of beta-catenin protein indicates activation of wnt signaling in chemically induced rat nephroblastomas.
Ehrlich D; Bruder E; Thome MA; Gutt CN; von Knebel Doeberitz M; Niggli F; Perantoni AO; Koesters R
Pediatr Dev Pathol; 2010; 13(1):1-8. PubMed ID: 19348510
[TBL] [Abstract][Full Text] [Related]
22. Pathology, genetics and cytogenetics of Wilms' tumour.
Md Zin R; Murch A; Charles A
Pathology; 2011 Jun; 43(4):302-12. PubMed ID: 21516053
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.
Royer-Pokora B; Beier M; Brandt A; Duhme C; Busch M; de Torres C; Royer HD; Mora J
Cancer Med; 2018 Apr; 7(4):1359-1368. PubMed ID: 29542868
[TBL] [Abstract][Full Text] [Related]
24. Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities.
Haruta M; Arai Y; Sugawara W; Watanabe N; Honda S; Ohshima J; Soejima H; Nakadate H; Okita H; Hata J; Fukuzawa M; Kaneko Y
Genes Chromosomes Cancer; 2008 Aug; 47(8):712-27. PubMed ID: 18464243
[TBL] [Abstract][Full Text] [Related]
25. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
[TBL] [Abstract][Full Text] [Related]
26. Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.
Royer-Pokora B; Busch M; Beier M; Duhme C; de Torres C; Mora J; Brandt A; Royer HD
Hum Mol Genet; 2010 May; 19(9):1651-68. PubMed ID: 20106868
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa.
Murphy AJ; Axt JR; de Caestecker C; Pierce J; Correa H; Seeley EH; Caprioli RM; Newton MW; de Caestecker MP; Lovvorn HN
Int J Cancer; 2012 Sep; 131(6):E983-94. PubMed ID: 22437966
[TBL] [Abstract][Full Text] [Related]
28. The development of Wilms tumor: from WT1 and microRNA to animal models.
Tian F; Yourek G; Shi X; Yang Y
Biochim Biophys Acta; 2014 Aug; 1846(1):180-7. PubMed ID: 25018051
[TBL] [Abstract][Full Text] [Related]
29. Paternally inherited WT1 mutation plus uniparental disomy of 11p may be an essential mechanism for development of WT1-mutated familial Wilms tumor.
Sato Y; Haruta M; Kaneko Y; Nakasato Y; Kurosawa H; Yoshihara S
Pediatr Blood Cancer; 2019 Jan; 66(1):e27442. PubMed ID: 30221469
[No Abstract] [Full Text] [Related]
30. Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors.
Amini Nik S; Hohenstein P; Jadidizadeh A; Van Dam K; Bastidas A; Berry RL; Patek CE; Van der Schueren B; Cassiman JJ; Tejpar S
Int J Cancer; 2005 Mar; 114(2):202-8. PubMed ID: 15540161
[TBL] [Abstract][Full Text] [Related]
31. Responsiveness of chemotherapy based on the histological type and Wilms' tumor suppressor gene mutation in bilateral Wilms' tumor.
Shibata R; Takata A; Hashiguchi A; Umezawa A; Yamada T; Hata J
Pathol Int; 2003 Apr; 53(4):214-20. PubMed ID: 12675764
[TBL] [Abstract][Full Text] [Related]
32. β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors.
Clark PE; Polosukhina D; Love H; Correa H; Coffin C; Perlman EJ; de Caestecker M; Moses HL; Zent R
Am J Pathol; 2011 Dec; 179(6):3045-55. PubMed ID: 21983638
[TBL] [Abstract][Full Text] [Related]
33. Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus.
El-Kares R; Hueber PA; Blumenkrantz M; Iglesias D; Ma K; Jabado N; Bichet DG; Goodyer P
Pediatr Nephrol; 2009 Jul; 24(7):1313-9. PubMed ID: 19294427
[TBL] [Abstract][Full Text] [Related]
34. Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin.
Royer-Pokora B; Wruck W; Adjaye J; Beier M
PLoS One; 2023; 18(1):e0270380. PubMed ID: 36689432
[TBL] [Abstract][Full Text] [Related]
35. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor].
Jiang YP; Shen Y; Sun N; Wang H
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811
[TBL] [Abstract][Full Text] [Related]
36. Bilateral Wilms tumor and early presentation in pediatric patients is associated with the truncation of the Wilms tumor 1 protein.
Hu M; Fletcher J; McCahon E; Catchpoole D; Zhang GY; Wang YM; Algar EM; Alexander SI
J Pediatr; 2013 Jul; 163(1):224-9. PubMed ID: 23403252
[TBL] [Abstract][Full Text] [Related]
37. A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation.
Sakamoto J; Takata A; Fukuzawa R; Kikuchi H; Sugiyama M; Kanamori Y; Hashizume K; Hata JI
Pediatr Res; 2001 Sep; 50(3):337-44. PubMed ID: 11518820
[TBL] [Abstract][Full Text] [Related]
38. Two molecular subgroups of Wilms' tumors with or without WT1 mutations.
Schumacher V; Schuhen S; Sonner S; Weirich A; Leuschner I; Harms D; Licht J; Roberts S; Royer-Pokora B
Clin Cancer Res; 2003 Jun; 9(6):2005-14. PubMed ID: 12796362
[TBL] [Abstract][Full Text] [Related]
39. WT1 mutations may be a cause of severe renal failure due to nephroblastomatosis in Wilms' tumor patients.
Santín S; Fraga G; Ruíz P; Pardo N; Torrent M; Martí T; Ballarín J; Ars E; Torra R
Clin Nephrol; 2011 Sep; 76(3):244-8. PubMed ID: 21888862
[TBL] [Abstract][Full Text] [Related]
40. A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16.
Kim MK; Mason JM; Li CM; Berkofsky-Fessler W; Jiang L; Choubey D; Grundy PE; Tycko B; Licht JD
Neoplasia; 2008 Jan; 10(1):69-78. PubMed ID: 18231640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
